In today’s recent session, 219.0 million shares of the Aspire Biopharma Holdings Inc (NASDAQ:ASBP) have been traded, and its beta is 0.62. Most recently the company’s share price was $0.65, and it changed around $0.41 or 175.75% from the last close, which brings the market valuation of the company to $32.44M. ASBP at last check was trading at a discount to its 52-week high of $15.80, offering almost -2330.77% off that amount. The share price’s 52-week low was $0.22, which indicates that the recent value has risen by an impressive 66.15% since then. We note from Aspire Biopharma Holdings Inc’s average daily trading volume that its 10-day average is 1.47 million shares, with the 3-month average coming to 732.08K.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

Instantly ASBP has been showing a green trend so far today with a performance of 175.75% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4826 on recent trading daydecreased the stock’s daily price by -34.69%. The company’s shares are currently down -94.31% year-to-date, but still up 172.53% over the last five days. On the other hand, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) is 44.57% up in the 30-day period. We can see from the shorts that 98369.0 shares have been sold at a short interest cover period of 0.51 day(s).

ASBP Dividends

Aspire Biopharma Holdings Inc’s next quarterly earnings report is expected to be released in June.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 33.50% of Aspire Biopharma Holdings Inc shares, and 2.95% of them are in the hands of institutional investors. The stock currently has a share float of 4.44%.

The former held 5.29 shares worth $2372.0, making up 0.01% of all outstanding shares.